Computationally driven molecular strategies of FDA-approved medications as potential inhibitors for the MurA and MurB enzymes to overcome Antimicrobial resistance
Comparative in-silico docking, pharmacokinetic characterization, and antimicrobial evaluation of 2,4-DTBP and chlorhexidine against gingivitis-associated oral pathogens
Authors: Seydina M. Diene; Lucile Pinault; Nicholas Armstrong; Said Azza; Vivek Keshri; Saber Khelaifia; Eric Chabrière; Gustavo Caetano-Anolles; Jean-Marc Rolain; Pierre Pontarotti; Didier Raoult